Clinical Trial Update: Immunogenicity of Intramuscular and Intradermal IPV [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating immunogenicity of intramuscular and intradermal inactivated polio vaccine (IPV) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Poliomyelitis | Phase 4 | Status: TERMINATED